Form 4: Snap-on Executive Exercises SARs, Sells Shares
Insider Transaction Report
Snap-on's Sr VP & President Commercial, Jesus Arregui, exercised stock appreciation rights and subsequently sold a portion of his common stock holdings.
Summary
- Jesus Arregui, Snap-on Inc.'s Sr VP & President Commercial, reported transactions involving the exercise of Stock Appreciation Rights (SARs) and subsequent sale of common stock.
- On November 25, 2025, Arregui exercised 6,500 Stock Appreciation Rights (SARs) at an exercise price of $138.03 per share.
- Concurrently, he disposed of 2,669 shares of common stock at $336.23, likely for tax withholding purposes related to the SAR exercise.
- He also sold 960 shares of common stock at a weighted average price of $336.4838 and an additional 2,871 shares at a weighted average price of $337.5454.
- These transactions resulted in a net decrease of 6,500 shares in his direct beneficial ownership of common stock, reducing his holdings from 9,142.335 to 2,642.335 shares.
- The filing indicates these transactions were made pursuant to a Rule 10b5-1 pre-arranged trading plan.
Sentiment
Score: 5
Explanation: This Form 4 reports a routine insider transaction involving the exercise of stock appreciation rights and subsequent sale of common stock for profit realization and tax purposes. It does not inherently indicate a positive or negative outlook for the company's future performance.
Positives
- The executive realized a significant profit by exercising Stock Appreciation Rights (SARs) with a strike price of $138.03 and selling the underlying common stock at substantially higher market prices (weighted average prices of $336.4838 and $337.5454).
Negatives
- The executive reduced his direct beneficial ownership of Snap-on common stock by 6,500 shares, which included sales for cash and disposition for tax withholding.
Stakeholder Impact
- Shareholders will observe the executive's transaction, which is a common practice for executive compensation and liquidity management. It reflects the executive realizing value from previously granted equity awards.
Key Dates
| Date | Description |
|---|---|
| 2023-2025 period | Performance units vesting period, contingent on company achieving certain goals. |
| 2024-2026 period | Performance units vesting period, contingent on company achieving certain goals. |
| 02/09/2024 | Date exercisable for Stock Appreciation Rights with an exercise price of $249.26. |
| 02/15/2025 | Date exercisable for Stock Appreciation Rights with an exercise price of $269. |
| 11/25/2025 | Date of earliest transaction (exercise of SARs and subsequent sales of common stock). |
| 2025-2027 period | Performance units vesting period, contingent on company achieving certain goals. |
| 02/09/2026 | Vesting date for Restricted Stock Units and expiration date for some Stock Appreciation Rights. |
| 02/11/2026 | Expiration date for exercised Stock Appreciation Rights. |
| 02/13/2026 | Date exercisable for Stock Appreciation Rights with an exercise price of $339.73. |
| 02/09/2027 | Vesting date for Restricted Stock Units and expiration date for some Stock Appreciation Rights. |
| 02/15/2027 | Vesting date for Restricted Stock Units. |
| 02/13/2028 | Vesting date for Restricted Stock Units and expiration date for some Stock Appreciation Rights. |
| 02/15/2028 | Expiration date for some Stock Appreciation Rights. |
| 02/13/2030 | Expiration date for some Stock Appreciation Rights. |
| 02/11/2031 | Expiration date for some Stock Appreciation Rights. |
| 02/10/2032 | Expiration date for some Stock Appreciation Rights. |
| 02/09/2033 | Expiration date for some Stock Appreciation Rights. |
| 02/15/2034 | Expiration date for some Stock Appreciation Rights. |
| 02/13/2035 | Expiration date for some Stock Appreciation Rights. |
Recommendation
holdThis Form 4 reports a routine insider transaction where an executive exercised stock appreciation rights and sold shares, likely for profit realization and tax purposes, under a pre-arranged plan. It does not provide new information about the company's operational performance or strategic direction that would warrant a change in investment recommendation.
Keywords
Snap-on Inc, SNA, Insider Trading, Form 4, Stock Appreciation Rights, SARs, Executive Compensation, Stock Sale, Jesus Arregui, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.